Searched for
OM MANCHANDA
Dr Lal PathLabs Q4 Results: Net profit rises 51% YoY to Rs 86 crore on improved volumes of diagnostic testsDr Lal PathLabs on Friday reported a 51% year-on-year (YoY) jump in net profit to Rs 86 crore in the quarter ended March 2024 led by improv...- Dr Lal PathLabs Q2 Results: Net profit rises 53%YoY to Rs 111 croreDr Lal PathLabs reported a Rs 72 crore net profit during the corresponding period of the previous year. Revenues rose 12.6% to Rs 601 crore...
- Dr Lal PathLabs Q1 FY24 net profit rises 44% to Rs 84 croreDr Lal PathLabs' Q1FY24 net profit surged 44% YoY to INR84 crore due to the rise in non-Covid testing and higher realisations, while non-Co...
- Dr Lal PathLabs Q3 Results: Net profit drops 8% to Rs 54 croreDr Lal PathLabs said its emphasis is on improving the market penetration through franchisee model, and leveraging the digital infrastructur...
- Dr Lal PathLabs to ramp up operations in Western India"The new reference lab provides a wide array of super-specialised, specialised and routine diagnostic tests for meeting all diagnostic need...
- Dr Lal pulls up its socks as competition mountsGurgaon-headquartered Dr Lal PathLabs and other diagnostic chains are feeling the heat due to the big drop in demand for Covid-19 testing, ...
- Dr Lal PathLabs pulls up its socks as competition mountsGurgaon-headquartered Dr Lal PathLabs and other diagnostic chains are feeling the heat due to the big drop in demand for Covid-19 testing, ...
- Dr Lal PathLabs Q2 results: Net profit up 7.5% to Rs 87 crRevenue from operations stood at Rs 431.9 crore for the quarter under consideration. It was Rs 365.6 crore for the same period a year ago, ...
- Dr Lal PathLabs to acquire 70 pc stake in Amins Pathology Referral LaboratoryThe acquisition will further strengthen the company's network in Gujarat and adjoining areas
- We have registered the highest ever turnover and volume growth in Q2: Om Manchanda, Dr Lal PathLabs“We have now strong tailwinds coming in because we have favourable base as well.”
- Normally Q2 is the highest quarter both in terms of revenue as well as volume: Om Prakash Manchanda, Whole-time Director & CEO, Dr Lal Pathlabs LtdIn an interview with ET Now, Om Prakash Manchanda, Whole-time Director & CEO, Dr Lal Pathlabs Ltd, gives his views on the company's Q2 resu...
- Leaders must be able to be in the shoes of people they manage: Om Manchanda, Dr Lal PathLabs CEOManchanda says the program he wrote on Lotus that helped the factory to monitor technical efficiencies was his biggest innovation during th...
- Dr Lal PathLabs eyeing 18 per cent growth in FY17"We are aiming for around 18% growth in the current fiscal. We have been growing at that rate and will like to keep the momentum," Dr Lal P...
- Dr Lal PathLabs eyes wider footprint to drive growthWhile deepening its presence in the North Indian market where it already has a strong presence, the company is looking to scale up in other...
- Diagnostic sector is growing at 17% & we continue to see same momentum: Om Manchanda, CEO, Dr Lal PathLabsIn an exclusive interaction with ET NOW, Om Manchanda, CEO, Dr Lal PathLabs talks about how diagnostic as a sector has got created in last ...
- Alkem Labs, Dr Lal PathLabs listings to help drive expansionAlkem Labs and Dr Lal PathLabs made an impressive start at the bourses on Wednesday, opening 31 per cent and 50 per cent higher from their ...
- Dr Lal Pathlabs looking to expand; 20% CAGR likely to sustain: Om Prakash Manchanda, CEO"The market is growing at 16% to 17%. Our own growth is likely to be sustainable as we expand to newer markets and grow further — both orga...
- Dr Lal PathLabs IPO to hit markets soonLeading diagnostic chain Dr Lal PathLabs, which has received capital markets regulator Sebi's approval to raise funds, hopes to launch an i...
- Dr Lal Path Labs eying revenues of Rs 350 cr in FY12Dr Lal Path Labs, which operates Asia's largest diagnostics centre in the capital, runs 70 laboratories across the country.
- Healthcare sector demands rollback of service taxPharma industry also fears imposition of MAT on Special Economic Zones would adversely impact their profits, since most export units of dru...
Load More
